Trade Cogent Biosciences, Inc. - COGT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 8.94 |
| Open | 9 |
| 1-Year Change | 89.47% |
| Day's Range | 8.93 - 9.25 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 4, 2025 | 9.20 | 0.32 | 3.60% | 8.88 | 9.25 | 8.87 |
| Feb 3, 2025 | 8.94 | -0.06 | -0.67% | 9.00 | 9.14 | 8.89 |
| Jan 31, 2025 | 9.26 | -0.36 | -3.74% | 9.62 | 9.74 | 8.96 |
| Jan 30, 2025 | 9.57 | -0.01 | -0.10% | 9.58 | 10.10 | 9.47 |
| Jan 29, 2025 | 9.26 | 0.54 | 6.19% | 8.72 | 9.41 | 8.71 |
| Jan 28, 2025 | 8.88 | 0.51 | 6.09% | 8.37 | 8.97 | 8.22 |
| Jan 27, 2025 | 8.42 | 0.10 | 1.20% | 8.32 | 8.67 | 8.28 |
| Jan 24, 2025 | 8.30 | -0.42 | -4.82% | 8.72 | 8.88 | 8.18 |
| Jan 23, 2025 | 8.85 | 0.73 | 8.99% | 8.12 | 8.99 | 7.86 |
| Jan 22, 2025 | 8.15 | -0.05 | -0.61% | 8.20 | 8.28 | 8.07 |
| Jan 21, 2025 | 8.16 | 0.19 | 2.38% | 7.97 | 8.19 | 7.73 |
| Jan 17, 2025 | 7.98 | -0.15 | -1.85% | 8.13 | 8.14 | 7.78 |
| Jan 16, 2025 | 8.08 | -0.02 | -0.25% | 8.10 | 8.39 | 7.97 |
| Jan 15, 2025 | 8.07 | 0.16 | 2.02% | 7.91 | 8.64 | 7.76 |
| Jan 14, 2025 | 7.32 | -0.19 | -2.53% | 7.51 | 7.66 | 7.12 |
| Jan 13, 2025 | 7.53 | -0.09 | -1.18% | 7.62 | 7.69 | 6.56 |
| Jan 10, 2025 | 7.80 | -0.07 | -0.89% | 7.87 | 7.92 | 7.63 |
| Jan 8, 2025 | 8.08 | -0.01 | -0.12% | 8.09 | 8.37 | 8.01 |
| Jan 7, 2025 | 8.21 | 0.24 | 3.01% | 7.97 | 8.33 | 7.97 |
| Jan 6, 2025 | 8.02 | 0.15 | 1.91% | 7.87 | 8.52 | 7.87 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Cogent Biosciences, Inc. Company profile
About Cogent Biosciences Inc
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. The Company's most advanced program is CGT9486, a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation, as well as other mutations in KIT exon 17, to treat Systemic Mastocytosis (SM) and gastrointestinal stromal tumors (GIST). GT9486 has demonstrated clinical activity and safety results in a Phase I/II clinical trial in patients with GIST, supporting accelerated timelines to proof-of-concept in SM.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cogent Biosciences Inc revenues decreased from $7.9M to $0K. Net loss applicable to common stockholders decreased 60% to $72.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Acquired in-process research and develop decrease from $46.9M (expense) to $0K, Other income increase from $779K to $2.5M (income).
| Industry: | Bio Therapeutic Drugs |
275 Wyman Street
3rd Floor
WALTHAM
MASSACHUSETTS 02451
US
News
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com